<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:38:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5789728" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5789728</identifier>
        <datestamp>2018-02-08</datestamp>
        <setSpec>physrep</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Physiol Rep</journal-id>
              <journal-id journal-id-type="iso-abbrev">Physiol Rep</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2051-817X</journal-id>
              <journal-id journal-id-type="publisher-id">PHY2</journal-id>
              <journal-id journal-id-type="hwp">physreports</journal-id>
              <journal-title-group>
                <journal-title>Physiological Reports</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2051-817X</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5789728</article-id>
              <article-id pub-id-type="pmcid">PMC5789728</article-id>
              <article-id pub-id-type="pmc-uid">5789728</article-id>
              <article-id pub-id-type="pmid">29368802</article-id>
              <article-id pub-id-type="doi">10.14814/phy2.13575</article-id>
              <article-id pub-id-type="publisher-id">PHY213575</article-id>
              <article-categories>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Endurance and Performance</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Nutrition</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Neuromuscular Junction</subject>
                </subj-group>
                <subj-group subj-group-type="article-subject-classification">
                  <subject>Muscle Structure and Function</subject>
                </subj-group>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Dietary nitrate‐induced increases in human muscle power: high versus low responders</article-title>
                <alt-title alt-title-type="left-running-head">A. R. Coggan <italic>et al</italic>.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="phy213575-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Coggan</surname>
                    <given-names>Andrew R.</given-names>
                  </name>
                  <address>
                    <email>acoggan@iupui.edu</email>
                  </address>
                  <xref ref-type="aff" rid="phy213575-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="phy213575-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="phy213575-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0002" contrib-type="author">
                  <name>
                    <surname>Broadstreet</surname>
                    <given-names>Seth R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0003" contrib-type="author">
                  <name>
                    <surname>Mikhalkova</surname>
                    <given-names>Deana</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0004" contrib-type="author">
                  <name>
                    <surname>Bole</surname>
                    <given-names>Indra</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0005" contrib-type="author">
                  <name>
                    <surname>Leibowitz</surname>
                    <given-names>Joshua L.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0006" contrib-type="author">
                  <name>
                    <surname>Kadkhodayan</surname>
                    <given-names>Ana</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0007" contrib-type="author">
                  <name>
                    <surname>Park</surname>
                    <given-names>Soo</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0008" contrib-type="author">
                  <name>
                    <surname>Thomas</surname>
                    <given-names>Deepak P.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0009" contrib-type="author">
                  <name>
                    <surname>Thies</surname>
                    <given-names>Dakkota</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="phy213575-cr-0010" contrib-type="author">
                  <name>
                    <surname>Peterson</surname>
                    <given-names>Linda R.</given-names>
                  </name>
                  <xref ref-type="aff" rid="phy213575-aff-0003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="aff" rid="phy213575-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="phy213575-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Departments of Kinesiology</named-content>
                <institution>Indiana University Purdue University Indianapolis</institution>
                <named-content content-type="city">Indianapolis</named-content>
                <country>Indiana</country>
              </aff>
              <aff id="phy213575-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Cellular and Integrative Physiology</named-content>
                <institution>Indiana University Purdue University Indianapolis</institution>
                <named-content content-type="city">Indianapolis</named-content>
                <country>Indiana</country>
              </aff>
              <aff id="phy213575-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Departments of Radiology</named-content>
                <institution>Washington University School of Medicine</institution>
                <named-content content-type="city">St. Louis</named-content>
                <named-content content-type="country-part">Missouri</named-content>
              </aff>
              <aff id="phy213575-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Medicine</named-content>
                <institution>Washington University School of Medicine</institution>
                <named-content content-type="city">St. Louis</named-content>
                <named-content content-type="country-part">Missouri</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Andrew R. Coggan, Department of Kinesiology, Indiana University Purdue University Indianapolis, IF 101C, 250 University Boulevard, Indianapolis, IN 46202.<break/>
Tel: 317 274 0656<break/>
Fax: 317 278 2041<break/>
E‐mail: <email>acoggan@iupui.edu</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>25</day>
                <month>1</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>1</month>
                <year>2018</year>
              </pub-date>
              <volume>6</volume>
              <issue>2</issue>
              <issue-id pub-id-type="doi">10.1002/phy2.2018.6.issue-2</issue-id>
              <elocation-id>e13575</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>10</month>
                  <year>2017</year>
                </date>
                <date date-type="rev-recd">
                  <day>12</day>
                  <month>12</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>13</day>
                  <month>12</month>
                  <year>2017</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 Published by the American Physiological Society and The Physiological Society <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2018 The Authors. <italic>Physiological Reports</italic> published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:PHY2-6-e13575.pdf"/>
              <abstract id="phy213575-abs-0001">
                <title>Abstract</title>
                <p>Maximal neuromuscular power is an important determinant of athletic performance and also quality of life, independence, and perhaps even mortality in patient populations. We have shown that dietary nitrate (<styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup>), a source of nitric oxide (<styled-content style="fixed-case">NO</styled-content>), improves muscle power in some, but not all, subjects. The present investigation was designed to identify factors contributing to this interindividual variability. Healthy men (<italic>n</italic> = 13) and women (<italic>n</italic> = 7) 22–79 year of age and weighing 52.1–114.9 kg were studied using a randomized, double‐blind, placebo‐controlled, crossover design. Subjects were tested 2 h after ingesting beetroot juice (<styled-content style="fixed-case">BRJ</styled-content>) either containing or devoid of 12.3 ± 0.8 mmol of <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup>. Plasma <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup> and nitrite (<styled-content style="fixed-case">NO</styled-content>
<sub>2</sub>
<sup>−</sup>) were measured as indicators of <styled-content style="fixed-case">NO</styled-content> bioavailability and maximal knee extensor speed (<italic>V</italic>
<sub>max</sub>), power (<italic>P</italic>
<sub>max</sub>), and fatigability were determined via isokinetic dynamometry. On average, dietary <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup> increased (<italic>P</italic> &lt; 0.05) <italic>P</italic>
<sub>max</sub> by 4.4 ± 8.1%. Individual changes, however, ranged from −9.6 to +26.8%. This interindividual variability was not significantly correlated with age, body mass (inverse of <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup> dose per kg), body mass index (surrogate for body composition) or placebo trial <italic>V</italic>
<sub>max</sub> or fatigue index (in vivo indicators of muscle fiber type distribution). In contrast, the relative increase in Pmax was significantly correlated (<italic>r</italic> = 0.60; <italic>P</italic> &lt; 0.01) with the relative increase in plasma <styled-content style="fixed-case">NO</styled-content>
<sub>2</sub>
<sup>−</sup> concentration. In multivariable analysis female sex also tended (<italic>P</italic> = 0.08) to be associated with a greater increase in Pmax. We conclude that the magnitude of the dietary <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup>‐induced increase in muscle power is dependent upon the magnitude of the resulting increase in plasma <styled-content style="fixed-case">NO</styled-content>
<sub>2</sub>
<sup>−</sup> and possibly female sex.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="phy213575-kwd-0001">Fiber type</kwd>
                <kwd id="phy213575-kwd-0002">isokinetic dynamometry</kwd>
                <kwd id="phy213575-kwd-0003">nitric oxide</kwd>
                <kwd id="phy213575-kwd-0004">sex differences</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>Barnes‐Jewish Hospital Foundation</funding-source>
                </award-group>
                <award-group>
                  <funding-source>Washington University Mentors in Medicine and C‐STAR programs</funding-source>
                </award-group>
                <award-group>
                  <funding-source>Washington University Institute of Clinical and Translational Sciences</funding-source>
                  <award-id>UL1 TR000448</award-id>
                </award-group>
                <award-group>
                  <funding-source>National Institutes of Health</funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="8"/>
                <word-count count="5765"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>phy213575</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>January 2018</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.2 mode:remove_FC converted:30.01.2018</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="phy213575-cit-1001"><string-name><given-names>A. R.</given-names><surname>Coggan</surname></string-name>, <string-name><given-names>S. R.</given-names><surname>Broadstreet</surname></string-name>, <string-name><given-names>D.</given-names><surname>Mikhalkova</surname></string-name>, <string-name><given-names>I.</given-names><surname>Bole</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Leibowitz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kadkhodayan</surname></string-name>, <string-name><given-names>S.</given-names><surname>Park</surname></string-name>, <string-name><given-names>D. P.</given-names><surname>Thomas</surname></string-name>, <string-name><given-names>D.</given-names><surname>Thies</surname></string-name>, <string-name><given-names>L. R.</given-names><surname>Peterson</surname></string-name>. <article-title>Dietary nitrate‐induced increases in human muscle power: high versus low responders</article-title>. <source>Physiol Rep</source>, <volume>6</volume> (<issue>2</issue>), <year>2018</year>, <elocation-id>e13575</elocation-id>, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14814/phy2.13575">https://doi.org/10.14814/phy2.13575</ext-link>
</mixed-citation>
              </p>
              <fn-group id="phy213575-ntgp-0001">
                <fn fn-type="funding" id="phy213575-note-1001">
                  <p>
                    <bold>Funding Information</bold>
                  </p>
                  <p>Research reported in this publication was supported by the Barnes‐Jewish Hospital Foundation, the Washington University Mentors in Medicine and C‐STAR programs, and Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH).</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <sec id="phy213575-sec-0001">
              <title>Introduction</title>
              <p>Maximal neuromuscular power is an important determinant of athletic performance and is also highly significant from a clinical perspective, as reductions in power contribute to impaired quality of life, disability, and possibly even mortality in various patient populations (e.g., the elderly (Guralnik et al. <xref rid="phy213575-bib-0015" ref-type="ref">1994</xref>), heart failure (HF) patients (Hülsmann et al. <xref rid="phy213575-bib-0019" ref-type="ref">2004</xref>)). It is therefore noteworthy that recent studies have demonstrated that acute or chronic supplementation with dietary nitrate (NO<sub>3</sub>
<sup>−</sup>), a source of nitric oxide (NO) via the enterosalivary pathway (Lundberg and Weitzberg <xref rid="phy213575-bib-0027" ref-type="ref">2009</xref>), can influence muscle contractile properties (Haider and Folland <xref rid="phy213575-bib-0016" ref-type="ref">2014</xref>; Coggan et al. 2015a,b; Justice et al. <xref rid="phy213575-bib-0024" ref-type="ref">2015</xref>; Rimer et al. <xref rid="phy213575-bib-0036" ref-type="ref">2016</xref>; Whitfield et al. 2017). In a previous study, for example, we found that acute ingestion of NO<sub>3</sub>
<sup>−</sup> increased maximal knee extensor speed and power in healthy, untrained individuals by 11 and 6%, respectively, (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>). We observed a similar dietary NO<sub>3</sub>
<sup>−</sup>‐induced enhancement of maximal neuromuscular power in athletes (Rimer et al. <xref rid="phy213575-bib-0036" ref-type="ref">2016</xref>), and an even greater increase (i.e., 13%) in patients with HF (Coggan et al. 2015a). NO<sub>3</sub>
<sup>−</sup> (or nitrite (NO<sub>2</sub>
<sup>−</sup>)) ‐induced improvements in muscle contractility have also been observed in some (Haider and Folland <xref rid="phy213575-bib-0016" ref-type="ref">2014</xref>; Justice et al. <xref rid="phy213575-bib-0024" ref-type="ref">2015</xref>; Whitfield et al. <xref rid="phy213575-bib-0039" ref-type="ref">2017</xref>), albeit not all (Hoon et al. <xref rid="phy213575-bib-0018" ref-type="ref">2015</xref>), recent studies of voluntary or electrically stimulated isometric exercise.</p>
              <p>Based on these previous studies (Haider and Folland <xref rid="phy213575-bib-0016" ref-type="ref">2014</xref>; Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>,<xref rid="phy213575-bib-0009" ref-type="ref">b</xref>; Justice et al. <xref rid="phy213575-bib-0024" ref-type="ref">2015</xref>; Rimer et al. <xref rid="phy213575-bib-0036" ref-type="ref">2016</xref>; Whitfield et al. <xref rid="phy213575-bib-0039" ref-type="ref">2017</xref>), it therefore appears that dietary NO<sub>3</sub>
<sup>−</sup> can enhance the inherent contractile properties of human muscle. However, as with NO<sub>3</sub>
<sup>−</sup>‐induced improvements in endurance performance (Christensen et al. <xref rid="phy213575-bib-0006" ref-type="ref">2013</xref>; Boorsma et al. <xref rid="phy213575-bib-0004" ref-type="ref">2014</xref>) (or reductions in blood pressure (Kapil et al. <xref rid="phy213575-bib-0025" ref-type="ref">2010</xref>)), not all individuals seem to respond equally. Specifically, only about three‐fourths of the subjects we have studied previously have demonstrated improvements in muscle speed and/or power with NO<sub>3</sub>
<sup>−</sup> intake. The reason for this variability between individuals is not clear, but it may be related to the extent to which NO<sub>3</sub>
<sup>−</sup> intake increases NO bioavailability. This hypothesis is suggested by the key role played by oral bacteria in reducing ingested NO<sub>3</sub>
<sup>−</sup> to NO<sub>2</sub>
<sup>−</sup>, the immediate precursor for NO synthesis via the enterosalivary pathway (Lundberg and Weitzberg <xref rid="phy213575-bib-0027" ref-type="ref">2009</xref>). Alternatively and/or in addition, based in part on animal studies it has been proposed that the effects of dietary NO<sub>3</sub>
<sup>−</sup> supplementation are greatest in type II, or fast‐twitch, muscle fibers (Jones et al. <xref rid="phy213575-bib-0023" ref-type="ref">2016</xref>). The interindividual variability in muscle power improvements that we have observed therefore may be related to differences in muscle fiber type distribution.</p>
              <p>The purpose of this study was to test the hypothesis that interindividual differences in the effects of dietary NO<sub>3</sub>
<sup>−</sup> on muscle function are related to interindividual differences in NO production and/or in the percentage of fast‐twitch muscle fibers. To do so, we determined the relationship between changes in muscle power due to NO<sub>3</sub>
<sup>−</sup> ingestion and markers of NO bioavailability (i.e., plasma NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> levels) and muscle fiber type (i.e., maximal knee extensor velocity (Vmax) and fatigability in the absence of NO<sub>3</sub>
<sup>−</sup> intake) in a heterogeneous group of healthy men and women. We recruited subjects widely varying in other characteristics (e.g., age) as well, to determine whether there was any relationship between such factors and the response to dietary NO<sub>3</sub>
<sup>−</sup>. The results of this study provide insight into the mechanisms responsible for interindividual differences in the effects of NO<sub>2</sub>
<sup>−</sup> supplementation on muscle power, which may prove useful in optimizing this intervention in both athletes and clinical populations.</p>
            </sec>
            <sec id="phy213575-sec-0002">
              <title>Methods</title>
              <sec id="phy213575-sec-0003">
                <title>Subjects</title>
                <p>We studied 13 men and 7 women ranging in age from 22 to 79 (mean 47 ± 20) years, in body mass from 52.1 to 114.9 (mean 78.2 ± 16.3) kg, and in body mass index (BMI) from 19.1 to 32.6 (mean 25.8 ± 4.2) kg/m<sup>2</sup>. All of the subjects were healthy, based upon medical history, physical examination, and standard blood chemistries. Although all were normally active, only two exercised regularly, and none were engaged in training for competitive sports. None of the subjects smoked. Additional exclusion criteria included use of drugs that can block reduction of NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> to NO (i.e., prescription sex hormones, antacids, proton pump inhibitors, or xanthine oxidase inhibitors) (Lundberg et al. <xref rid="phy213575-bib-0028" ref-type="ref">1994</xref>; Obach et al. <xref rid="phy213575-bib-0034" ref-type="ref">2004</xref>) or can potentiate the effects of the latter (i.e., phosphodiesterase inhibitors) (Webb et al. <xref rid="phy213575-bib-0038" ref-type="ref">1999</xref>). Women who were pregnant or lactating were also excluded. Approval for the study was obtained from the Human Subjects Office at Indiana University and the Human Research Protection Office at Washington University School of Medicine, and all subjects provided written, informed consent. Partial data from some of these subjects has been presented previously (Coggan et al. <xref rid="phy213575-bib-0009" ref-type="ref">2015b</xref>).</p>
              </sec>
              <sec id="phy213575-sec-0004">
                <title>Experimental design and protocol</title>
                <p>Each subject was studied twice using a double‐blind, placebo‐controlled, randomized design. During one trial, subjects were tested after ingesting 140 mL of a commercial beetroot juice (BRJ) supplement (Beet It<sup>®</sup>, James White Drinks, Ipswich, UK) containing 12.3 ± 0.8 mmol of NO<sub>3</sub>
<sup>−</sup>. During the other trial, they ingested an equal volume of concentrated BRJ from which the NO<sub>3</sub>
<sup>−</sup> had been removed by the manufacturer. A washout period of 1–2 weeks separated the two trials (i.e., NO<sub>3</sub>
<sup>−</sup> vs. placebo). Since use of an antibacterial mouthwash, tooth brushing, or chewing gum can block the conversion of NO<sub>3</sub>
<sup>−</sup> to NO<sub>2</sub>
<sup>−</sup> by oral bacteria (Lundberg et al. <xref rid="phy213575-bib-0028" ref-type="ref">1994</xref>; Govoni et al. <xref rid="phy213575-bib-0013" ref-type="ref">2008</xref>), subjects were instructed to avoid these behaviors on study days. They were also instructed to avoid high NO<sub>3</sub>
<sup>−</sup> foods throughout the study, with adherence to this instruction verified by analysis of food records by a dietician.</p>
                <p>Subjects arrived at the Clinical Research Unit in the morning after avoiding food, caffeine, or alcohol intake for the previous 12 h. A catheter was first inserted in an antecubital vein and a blood sample obtained for subsequent measurement of plasma NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> concentrations via high‐performance liquid chromatography (ENO‐30, Eicom USA, San Diego, CA). These measurements were repeated and 2 h of quiet rest, after which the contractile properties of the knee extensor muscles of the subject's dominant leg were determined using an isokinetic dynamometer (Biodex System 4 Pro, Biodex Medical Systems, Shirley, NY) as previously described (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>,<xref rid="phy213575-bib-0009" ref-type="ref">b</xref>). Briefly, each subject performed 3–4 maximal knee extensions at angular velocities of 0, 1.57, 3.14, 4.71, and 6.28 rad/sec, with 2 min of rest between each set. The resulting torque data were filtered and smoothed to eliminate artifacts, after which peak power was calculated by multiplying the peak torque observed at each velocity by that velocity. The power‐velocity data were then fit with a parabolic function to determine the subject's <italic>V</italic>
<sub>max</sub> and maximal power (<italic>P</italic>
<sub>max</sub>). After an additional 2 min of rest, the subject performed 50 consecutive maximal knee extensions at an angular velocity of 3.14 rad/sec to determine their resistance to fatigue (i.e., fatigue index, =% decrease in power from first 1/3 to last 1/3 of the test) during repeated muscle contractions. Following a 10 min rest period, the final plasma samples were obtained after which the subject was fed a light meal and released.</p>
              </sec>
              <sec id="phy213575-sec-0005">
                <title>Data analysis</title>
                <p>Statistical analyses were performed using GraphPad Prism version 7.02 (GraphPad Software, La Jolla, CA). Normality of data distribution was first tested using the D'Agostino‐Pearson omnibus test. Data from the placebo and NO<sub>3</sub>
<sup>−</sup> trials were subsequently compared using two‐way (treatment x order) ANOVA, with subject as a repeated measures factor within treatment. Intraclass correlation coefficients were calculated from the ANOVA results to quantify the reliability of the data. Standard Pearson product correlations were calculated to explore the relationship between relative changes in Pmax as the dependent variable and sex, age, body mass (inverse to NO<sub>3</sub>
<sup>−</sup> dose in <italic>μ</italic>mol/kg), BMI, placebo trial <italic>V</italic>
<sub>max</sub>, placebo trial fatigue index (in vivo indicators of muscle fiber type distribution), percent change in plasma NO<sub>3</sub>
<sup>−</sup>, or percent change in plasma NO<sub>2</sub>
<sup>−</sup> as independent variables. The overall false discovery rate was limited to 10% using the Benjamini–Hochberg procedure. As this was an exploratory study, stepwise forward regression was also employed using the same dependent and independent variables, with the <italic>P</italic> value to enter the model similarly set to 0.10.</p>
              </sec>
            </sec>
            <sec id="phy213575-sec-0006">
              <title>Results</title>
              <p>The effects of ingesting BRJ without or with NO<sub>3</sub>
<sup>−</sup> on plasma NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> concentrations are shown in Table <xref rid="phy213575-tbl-0001" ref-type="table-wrap">1</xref>. No significant changes occurred in the placebo trial, whereas during the NO<sub>3</sub>
<sup>−</sup> trial, both NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> increased significantly. This was accompanied by a significant (<italic>P</italic> &lt; 0.05) elevation in Vmax, which increased from 12.3 ± 2.5 (range: 9.3–20.2) rad/sec in the placebo trial to 13.2 ± 3.1 (range: 8.4–20.2) rad/sec in the NO<sub>3</sub>
<sup>−</sup> trial. Pmax also increased significantly (<italic>P</italic> &lt; 0.05), that is, from 6.3 ± 2.3 (range: 2.8–10.7) to 6.6 ± 2.4 (range: 2.7–11.8) W/kg. Individual changes varied from −9.6 to +26. % (Fig. <xref rid="phy213575-fig-0001" ref-type="fig">1</xref>). On the other hand, the fatigue index was unaltered by NO<sub>3</sub>
<sup>−</sup> intake, averaging 61 ± 13 (range: 34–78) and 61.6 ± 13.5 (range: 32–78)% during the placebo and NO<sub>3</sub>
<sup>−</sup> trials, respectively. All three performance measures were highly reliable, with intraclass correlation coefficients of 0.94, 0.98, and 0.89 for <italic>V</italic>
<sub>max</sub>, <italic>P</italic>
<sub>max</sub>, and fatigue index, respectively. No adverse effects were observed. These observations confirm and extend our previous findings (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>,<xref rid="phy213575-bib-0009" ref-type="ref">b</xref>; Rimer et al. <xref rid="phy213575-bib-0036" ref-type="ref">2016</xref>). The remainder of our effort therefore focused upon attempting to elucidate the factors responsible for the marked variability between subjects in the response to NO<sub>3</sub>
<sup>−</sup> intake.</p>
              <table-wrap id="phy213575-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                <label>Table 1</label>
                <caption>
                  <p>Changes in plasma NO<sub>3</sub>
<sup>−</sup> and NO<sub>2</sub>
<sup>−</sup> in response to NO<sub>3</sub>
<sup>−</sup>
</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <thead valign="top">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" rowspan="2" valign="top" colspan="1"/>
                      <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1"/>
                      <th align="center" colspan="4" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Time point</th>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="center" valign="top" rowspan="1" colspan="1">Trial</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Pre</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">1 h</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">2 h</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">10 min post</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="2" colspan="1">Plasma NO<sub>3</sub>
<sup>−</sup> (<italic>μ</italic>mol/L)</td>
                      <td align="center" rowspan="1" colspan="1">Placebo</td>
                      <td align="char" char="±" rowspan="1" colspan="1">26 ± 11</td>
                      <td align="char" char="±" rowspan="1" colspan="1">23 ± 9</td>
                      <td align="char" char="±" rowspan="1" colspan="1">22 ± 7</td>
                      <td align="char" char="±" rowspan="1" colspan="1">23 ± 11</td>
                    </tr>
                    <tr>
                      <td align="center" rowspan="1" colspan="1">Nitrate</td>
                      <td align="char" char="±" rowspan="1" colspan="1">30 ± 18</td>
                      <td align="char" char="±" rowspan="1" colspan="1">334 ± 111<xref ref-type="fn" rid="phy213575-note-0003">†</xref>
</td>
                      <td align="char" char="±" rowspan="1" colspan="1">351 ± 74<xref ref-type="fn" rid="phy213575-note-0003">†</xref>
</td>
                      <td align="char" char="±" rowspan="1" colspan="1">346 ± 91<xref ref-type="fn" rid="phy213575-note-0003">†</xref>
</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="2" colspan="1">Plasma NO<sub>2</sub>
<sup>−</sup> (<italic>μ</italic>mol/L)</td>
                      <td align="center" rowspan="1" colspan="1">Placebo</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.29 ± 0.22</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.30 ± 0.26</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.30 ± 0.28</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.29 ± 0.36</td>
                    </tr>
                    <tr>
                      <td align="center" rowspan="1" colspan="1">Nitrate</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.36 ± 0.40</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.44 ± 0.33<xref ref-type="fn" rid="phy213575-note-0003">*</xref>
</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.47 ± 0.34<xref ref-type="fn" rid="phy213575-note-0003">†</xref>
</td>
                      <td align="char" char="±" rowspan="1" colspan="1">0.57 ± 0.32<xref ref-type="fn" rid="phy213575-note-0003">†</xref>
</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="phy213575-note-0002">
                    <p>Values are mean ± SD for <italic>n</italic> = 19.</p>
                  </fn>
                  <fn id="phy213575-note-0003">
                    <p>Nitrate trial significantly higher than Placebo trial at same time point: *<italic>P</italic> &lt; 0.01, †<italic>P</italic> &lt; 0.0001.</p>
                  </fn>
                </table-wrap-foot>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                </permissions>
              </table-wrap>
              <fig fig-type="Figure" xml:lang="en" id="phy213575-fig-0001" orientation="portrait" position="float">
                <label>Figure 1</label>
                <caption>
                  <p>Individual relative changes in maximal knee extensor power (<italic>P</italic>
<sub>max</sub>) in response to dietary <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup> intake. <italic>Open bars</italic>, male subjects. <italic>Closed bars</italic>, female subjects. The overall average response is also shown (<italic>dashed line</italic>).</p>
                </caption>
                <graphic id="nlm-graphic-3" xlink:href="PHY2-6-e13575-g001"/>
              </fig>
              <p>In univariable analyses, the relative increase (i.e., Δ%) in Pmax due to dietary NO<sub>3</sub>
<sup>−</sup> ingestion was not significantly correlated with sex, age, body mass, or BMI, or with placebo trial Vmax or fatigue index (Table <xref rid="phy213575-tbl-0002" ref-type="table-wrap">2</xref>). The relative magnitude of the increase in <italic>P</italic>
<sub>max</sub> was also not correlated with the relative change in plasma NO<sub>3</sub>
<sup>−</sup> concentration (Table <xref rid="phy213575-tbl-0002" ref-type="table-wrap">2</xref>). There was, however, a significant correlation between the relative increase in Pmax and the relative increase in plasma NO<sub>2</sub>
<sup>−</sup> concentration due to NO<sub>3</sub>
<sup>−</sup> intake (Table <xref rid="phy213575-tbl-0002" ref-type="table-wrap">2</xref>; Fig. <xref rid="phy213575-fig-0002" ref-type="fig">2</xref>). The relative change in plasma NO<sub>2</sub>
<sup>−</sup> concentration was also the strongest predictor of relative changes in <italic>P</italic>
<sub>max</sub> in the multivariable analysis (Table <xref rid="phy213575-tbl-0003" ref-type="table-wrap">3</xref>). Female sex also tended to be a positive predictor of relative increases in Pmax in the multivariable analysis (Table <xref rid="phy213575-tbl-0003" ref-type="table-wrap">3</xref>). In keeping with this, female subjects tended (i.e., <italic>P</italic> = 0.06 by Fisher's exact test) to be more likely to exhibit a greater‐than‐average increase in Pmax, that is, to be “high responders” (Fig. <xref rid="phy213575-fig-0002" ref-type="fig">2</xref>). Taken together, the relative change in plasma NO<sub>2</sub>
<sup>−</sup> concentration and subject sex explained ~40% of the interindividual variation in the effect of NO<sub>3</sub>
<sup>−</sup> intake on muscle power (i.e., <italic>R</italic>
<sup>2</sup> of multivariable regression = 0.38).</p>
              <fig fig-type="Figure" xml:lang="en" id="phy213575-fig-0002" orientation="portrait" position="float">
                <label>Figure 2</label>
                <caption>
                  <p>Relationship of relative changes in maximal knee extensor power (<italic>P</italic>
<sub>max</sub>) to relative changes in plasma <styled-content style="fixed-case">NO</styled-content>
<sub>2</sub>
<sup>−</sup> concentration in response to dietary <styled-content style="fixed-case">NO</styled-content>
<sub>3</sub>
<sup>−</sup> intake. <italic>Open symbols</italic>, male subjects. <italic>Closed symbols</italic>, female subjects. Plasma samples from one female subject were not available for analysis; data for the remaining 19 subjects are therefore shown.</p>
                </caption>
                <graphic id="nlm-graphic-5" xlink:href="PHY2-6-e13575-g002"/>
              </fig>
              <table-wrap id="phy213575-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                <label>Table 2</label>
                <caption>
                  <p>Pearson‐product correlation coefficients between Δ% Pmax and potential explanatory variables</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <thead valign="top">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="top" rowspan="1" colspan="1">Sex</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Age</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Body mass</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">BMI</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Placebo <italic>V</italic>
<sub>max</sub>
</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Placebo fatigue index</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Δ% NO<sub>3</sub>
<sup>−</sup>
</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Δ% NO<sub>2</sub>
<sup>−</sup>
</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">0.31</td>
                      <td align="center" rowspan="1" colspan="1">−0.16</td>
                      <td align="center" rowspan="1" colspan="1">−0.16</td>
                      <td align="center" rowspan="1" colspan="1">0.10</td>
                      <td align="center" rowspan="1" colspan="1">0.08</td>
                      <td align="center" rowspan="1" colspan="1">−0.25</td>
                      <td align="center" rowspan="1" colspan="1">−0.05</td>
                      <td align="center" rowspan="1" colspan="1">0.60<xref ref-type="fn" rid="phy213575-note-0004">*</xref>
</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="phy213575-note-0004">
                    <p>*<italic>P</italic> &lt; 0.01.</p>
                  </fn>
                </table-wrap-foot>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                </permissions>
              </table-wrap>
              <table-wrap id="phy213575-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                <label>Table 3</label>
                <caption>
                  <p>Results of stepwise forward regression</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <thead valign="top">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="top" rowspan="1" colspan="1">Predictor</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Beta coefficient</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">SE</th>
                      <th align="char" char="." valign="top" rowspan="1" colspan="1">Lower 95% CI</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">Upper 95% CI</th>
                      <th align="center" valign="top" rowspan="1" colspan="1">
                        <italic>t</italic>
                      </th>
                      <th align="left" valign="top" rowspan="1" colspan="1">
                        <italic>P</italic>
                      </th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">Δ% NO<sub>2</sub>
<sup>−</sup>
</td>
                      <td align="center" rowspan="1" colspan="1">0.038</td>
                      <td align="center" rowspan="1" colspan="1">0.014</td>
                      <td align="char" char="." rowspan="1" colspan="1">0.011</td>
                      <td align="center" rowspan="1" colspan="1">0.064</td>
                      <td align="center" rowspan="1" colspan="1">2.81</td>
                      <td align="center" rowspan="1" colspan="1">0.005</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">Sex</td>
                      <td align="center" rowspan="1" colspan="1">0.056</td>
                      <td align="center" rowspan="1" colspan="1">0.032</td>
                      <td align="char" char="." rowspan="1" colspan="1">−0.006</td>
                      <td align="center" rowspan="1" colspan="1">0.118</td>
                      <td align="center" rowspan="1" colspan="1">1.76</td>
                      <td align="center" rowspan="1" colspan="1">0.079</td>
                    </tr>
                  </tbody>
                </table>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                </permissions>
              </table-wrap>
            </sec>
            <sec id="phy213575-sec-0007">
              <title>Discussion</title>
              <p>The purpose of this study was to identify (if possible) factors contributing to interindividual variability in improvements in muscle contractile function resulting from dietary NO<sub>3</sub>
<sup>−</sup> intake. Based on previous research, we hypothesized that such differences would be related to differences between individuals in markers of NO bioavailability and/or muscle fiber type. Consistent with the first hypothesis, we found a significant correlation between the relative increase in <italic>P</italic>
<sub>max</sub> and the relative increase in plasma NO<sub>2</sub>
<sup>−</sup> concentration due to NO<sub>3</sub>
<sup>−</sup> ingestion. Our second hypothesis, however, was not supported, as there was no association between the increase in <italic>P</italic>
<sub>max</sub> and baseline <italic>V</italic>
<sub>max</sub> or fatigue index, in vivo indicators of muscle fiber type distribution (see below). Finally, our data provide preliminary support for the novel hypothesis that, at least in terms of improvements in maximal neuromuscular power, women are more likely than men to benefit from dietary NO<sub>3</sub>
<sup>−</sup> supplementation.</p>
              <p>Reduction in NO<sub>3</sub>
<sup>−</sup> to NO<sub>2</sub>
<sup>−</sup> by oral bacteria plays a critical role in the production of NO via the enterosalivary pathway (Lundberg et al. <xref rid="phy213575-bib-0028" ref-type="ref">1994</xref>; Govoni et al. <xref rid="phy213575-bib-0013" ref-type="ref">2008</xref>; Lundberg and Weitzberg <xref rid="phy213575-bib-0027" ref-type="ref">2009</xref>). In fact, this step appears to be possibly rate‐limiting, as demonstrated by the much smaller increase in plasma NO<sub>2</sub>
<sup>−</sup> versus NO<sub>3</sub>
<sup>−</sup> following NO<sub>3</sub>
<sup>−</sup> ingestion (Table <xref rid="phy213575-tbl-0001" ref-type="table-wrap">1</xref>). Accordingly, previous studies have observed a significant correlation between the magnitude of the increase in plasma NO<sub>2</sub>
<sup>−</sup> following NO<sub>3</sub>
<sup>−</sup> ingestion and the improvement in endurance performance ability (Wilkerson et al. <xref rid="phy213575-bib-0040" ref-type="ref">2012</xref>; Hoon et al. <xref rid="phy213575-bib-0017" ref-type="ref">2014</xref>). Our results are similar, as we found that interindividual differences in how much plasma NO<sub>2</sub>
<sup>−</sup> concentration was elevated by NO<sub>3</sub>
<sup>−</sup> intake accounted for about one‐third of the variation between individuals in the increase in Pmax. It is possible that this significant correlation reflects a direct effect of NO<sub>2</sub>
<sup>−</sup> on muscle contractility. Indeed, in cardiac muscle NO<sub>2</sub>
<sup>−</sup> has been shown to nitrosylate cysteine residues of various membrane proteins independently of NO (Montesanti et al. <xref rid="phy213575-bib-0032" ref-type="ref">2014</xref>). In skeletal muscle, however, S‐nitrosylation is thought to inhibit contractile function; stimulatory effects are held to be the result of NO‐dependent soluble guanyl cyclase (sGC)/cyclic GMP (cGMP)/protein kinase G (PKG) signaling (Maréchal and Gaily <xref rid="phy213575-bib-0030" ref-type="ref">1999</xref>). A direct effect of NO<sub>2</sub>
<sup>−</sup> would therefore seemingly not explain the positive correlation we observed between changes in plasma NO<sub>2</sub>
<sup>−</sup> and changes in Pmax. Rather, this observation is consistent with our first hypothesis that interindividual differences in the availability of NO itself contribute to interindividual differences in the extent to which dietary NO<sub>3</sub>
<sup>−</sup> intake increases muscle power.</p>
              <p>Although we were able to at least partially confirm our first hypothesis, our data do not support our second hypothesis, which was that individuals with a greater percentage of fast‐twitch fibers would demonstrate a greater dietary NO<sub>3</sub>
<sup>−</sup>‐induced increase in muscle power. In particular, we found no correlation between the increase in Pmax and Vmax or fatigue index during the placebo trial. Although indirect, numerous previous studies have demonstrated that these (or comparable) measurements are significantly correlated with muscle fiber type (e.g., Coyle et al. <xref rid="phy213575-bib-0010" ref-type="ref">1979</xref>; Ivy et al. <xref rid="phy213575-bib-0020" ref-type="ref">1981</xref>; McCartney et al. <xref rid="phy213575-bib-0031" ref-type="ref">1983</xref>). Moreover, <italic>V</italic>
<sub>max</sub> and fatigue index were highly characteristic of a given subject, as indicated their high intraclass correlation coefficients. Given the strength of the association between muscle fiber type, speed, and fatigability found in previous studies (Coyle et al. <xref rid="phy213575-bib-0010" ref-type="ref">1979</xref>; Ivy et al. <xref rid="phy213575-bib-0020" ref-type="ref">1981</xref>; McCartney et al. <xref rid="phy213575-bib-0031" ref-type="ref">1983</xref>) along with the reproducibility of our measurements and the &gt;2‐fold range in <italic>V</italic>
<sub>max</sub> and fatigue index during the placebo trial, it seems unlikely that the lack of correlation of the latter measures with the magnitude of the increase in Pmax with NO<sub>3</sub>
<sup>−</sup> ingestion is the result a type II statistical error. On the other hand, the premise that dietary NO<sub>3</sub>
<sup>−</sup> supplementation selectively targets fast‐twitch fibers is based largely on animal studies of muscle blood flow and oxygenation during aerobic exercise, for example, (Ferguson et al. <xref rid="phy213575-bib-0011" ref-type="ref">2015</xref>), and is only indirectly supported by human data. Specifically, Bailey et al. (<xref rid="phy213575-bib-0002" ref-type="ref">2015</xref>) demonstrated dietary NO<sub>3</sub>
<sup>−</sup>‐induced differences in muscle oxygenation, whole‐body VO<sub>2</sub> kinetics, and performance during cycling when pedaling at 115 rpm but not at 35 rpm. Breese et al. (<xref rid="phy213575-bib-0005" ref-type="ref">2013</xref>) reported similar benefits during the transition from moderate to high‐intensity exercise but not from low to moderate intensity exercise. These data, along with the fact that we have previously reported that NO<sub>3</sub>
<sup>−</sup> improves muscle function only at higher velocities (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>,<xref rid="phy213575-bib-0009" ref-type="ref">b</xref>), have been interpreted by Jones et al. (<xref rid="phy213575-bib-0023" ref-type="ref">2016</xref>) as reflecting enhanced recruitment of fast‐twitch fibers at a higher velocities/intensities of exercise. It is unclear, however, whether altering pedaling rate in fact changes the pattern of motor unit recruitment (Ahlquist et al. <xref rid="phy213575-bib-0001" ref-type="ref">1992</xref>). Similarly, the relationship between exercise intensity and O<sub>2</sub> flux is complex, with motor unit recruitment being only one influencing factor (Jones et al. <xref rid="phy213575-bib-0022" ref-type="ref">2011</xref>). Finally, in both fast‐ <italic>and</italic> slow‐twitch muscle NO seems to improve contractile function by increasing the rate of cross‐bridge cycling, not the amount of force per cross‐bridge (Maréchal and Gaily <xref rid="phy213575-bib-0030" ref-type="ref">1999</xref>). The resultant shift in the force‐velocity (and hence power‐velocity) curve, and not a selective impact only in fast‐twitch fibers, may therefore explain why we have previously observed statistically significant NO<sub>3</sub>
<sup>−</sup>‐induced improvements in power only at higher speeds of contraction (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>,<xref rid="phy213575-bib-0009" ref-type="ref">b</xref>). The notion that dietary NO<sub>3</sub>
<sup>−</sup> affects only, or even primarily, human fast‐twitch fibers would therefore still seem equivocal.</p>
              <p>An unexpected observation in this study was that, at least in terms of improvements in Pmax, women seem to benefit more than men from dietary NO<sub>3</sub>
<sup>−</sup> intake. Specifically, although not significant in the univariable analyses, female sex was the only predictor other than plasma NO<sub>2</sub>
<sup>−</sup> concentration selected by the stepwise forward regression procedure. Female subjects also tended to be more to likely be “high responders” to NO<sub>3</sub>
<sup>−</sup> supplementation, with five out of seven demonstrating greater‐than‐average increases in <italic>P</italic>
<sub>max</sub>. This was true even though NO<sub>3</sub>
<sup>−</sup> intake increased plasma NO<sub>2</sub>
<sup>−</sup> concentration similarly in both women (i.e., +131 ± 162%) and men (i.e., +124 ± 93%). Previous studies of the effects of dietary NO<sub>3</sub>
<sup>−</sup> on exercise performance have included only male subjects (e.g., Christensen et al. <xref rid="phy213575-bib-0006" ref-type="ref">2013</xref>; Boorsma et al. <xref rid="phy213575-bib-0004" ref-type="ref">2014</xref>; Haider and Folland <xref rid="phy213575-bib-0016" ref-type="ref">2014</xref>; Hoon et al. <xref rid="phy213575-bib-0017" ref-type="ref">2014</xref>; Bailey et al. <xref rid="phy213575-bib-0002" ref-type="ref">2015</xref>; Whitfield et al. <xref rid="phy213575-bib-0039" ref-type="ref">2017</xref>), or have not commented on possible sex‐related differences (e.g., Breese et al. <xref rid="phy213575-bib-0005" ref-type="ref">2013</xref>; Hoon et al. <xref rid="phy213575-bib-0018" ref-type="ref">2015</xref>). It has been reported, however, that plasma NO<sub>3</sub>
<sup>−</sup> (Jilma et al. <xref rid="phy213575-bib-0021" ref-type="ref">1996</xref>; Ghasemi et al. <xref rid="phy213575-bib-0012" ref-type="ref">2008</xref>) and/or breath NO levels (Jilma et al. <xref rid="phy213575-bib-0021" ref-type="ref">1996</xref>; Olivieri et al. <xref rid="phy213575-bib-0035" ref-type="ref">2006</xref>) are lower in women. The reason for this difference is not known, but it may be due to suppression of NO production by progesterone (Scichilone et al. <xref rid="phy213575-bib-0037" ref-type="ref">2013</xref>) and/or a sex‐related difference in the distribution of a polymorphism in the neuronal NO synthase (NOS) gene (Grasemann et al. <xref rid="phy213575-bib-0014" ref-type="ref">2003</xref>). Regardless, lower NO bioavailability under baseline conditions could explain why the women seemed to be more responsive to dietary NO<sub>3</sub>
<sup>−</sup> intake. Indeed, we have previously observed an approximately twofold greater dietary NO<sub>3</sub>‐induced improvement in muscle power in patients with HF (Coggan et al. <xref rid="phy213575-bib-0008" ref-type="ref">2015a</xref>) compared to healthy control subjects (Coggan et al. <xref rid="phy213575-bib-0009" ref-type="ref">2015b</xref>) or athletes (Rimer et al. <xref rid="phy213575-bib-0036" ref-type="ref">2016</xref>), presumably because of diminished NOS‐mediated NO production (Katz et al. <xref rid="phy213575-bib-0026" ref-type="ref">1999</xref>) and enhanced NO destruction (Münzel et al. <xref rid="phy213575-bib-0033" ref-type="ref">2015</xref>) in patients with HF. Somewhat along the same lines, Kapil et al. (<xref rid="phy213575-bib-0025" ref-type="ref">2010</xref>) found that changes in blood pressure in response to NO<sub>3</sub>
<sup>−</sup> ingestion were greatest in individuals with lower baseline plasma NO<sub>2</sub>
<sup>−</sup> concentrations (and higher baseline blood pressures), although in this case it was men who benefited the most. In any case, future studies should more directly address possible sex‐related differences in the effects of NO<sub>3</sub>
<sup>−</sup> ingestion on exercise performance.</p>
              <p>There are a number of limitations to this study. The most obvious is that muscle biopsies were not performed to directly determine fiber type distribution, which potentially could have revealed a relationship between the percentage of fast‐twitch fibers and the relative increase in Pmax. Our study also included a relatively small number of individuals, only two of which were regular exercisers and none of whom were presently competing in endurance sports. Whether similar results would be obtained in a larger group of subjects and/or among athletes therefore cannot be determined from the present data. Although we used a randomized, placebo‐controlled, cross‐over design, there were no significant order effects, and <italic>P</italic>
<sub>max</sub>, <italic>V</italic>
<sub>max</sub>, and fatigue index proved to be highly reliable, it is possible that inclusion of a familiarization trial would have altered the results (especially in the several subjects in whom NO<sub>3</sub>
<sup>−</sup> ingestion seemed to impair muscle function.</p>
              <p>Finally, although we have been able to identify two factors (i.e., plasma NO<sub>2</sub>
<sup>−</sup> concentration and possibly subject sex) contributing to interindividual differences in the effects of dietary NO<sub>3</sub>‐ on muscle contractile function, it must be emphasized that over half of this variability remains unexplained. Of course, some of this variability represents normal day‐to‐day variation in human performance (Coggan and Costill <xref rid="phy213575-bib-0007" ref-type="ref">1984</xref>), and is not due to NO<sub>3</sub>
<sup>−</sup> ingestion per se. Such random variability, however, could not explain the wide range of responses we observed, and as indicated previously measurement of <italic>P</italic>
<sub>max</sub> was highly reproducible. Additional studies measuring NO<sub>3</sub>
<sup>−</sup> reduction in the mouth as well as NO/sGC/cGMP/PKG signaling in muscle may provide further insight into the mechanism(s) responsible for this marked interindividual variability in the effects of dietary NO<sub>3</sub>
<sup>−</sup> on muscle power.</p>
              <p>In summary, in this study we sought to identify factors influencing the magnitude of the improvement in muscle power due to dietary NO<sub>3</sub>
<sup>−</sup> intake. Our findings indicate that variable increases in NO bioavailability, as indicated by changes in plasma NO<sub>2</sub>
<sup>−</sup> concentration, along with subject sex account for ~40% of this variability. On the other hand, interindividual differences in muscle fiber type do not appear to be important. Much of the variation in response between individuals remains unexplained.</p>
            </sec>
            <sec id="phy213575-sec-0009">
              <title>Conflict of Interest</title>
              <p>None to declare.</p>
            </sec>
          </body>
          <back>
            <ack id="phy213575-sec-0008">
              <title>Acknowledgments</title>
              <p>The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.</p>
            </ack>
            <ref-list content-type="cited-references" id="phy213575-bibl-0001">
              <title>References</title>
              <ref id="phy213575-bib-0001">
                <mixed-citation publication-type="journal" id="phy213575-cit-0001"><string-name><surname>Ahlquist</surname>, <given-names>L. E.</given-names></string-name>, <string-name><given-names>D. R.</given-names><suffix>Jr</suffix><surname>Bassett</surname></string-name>, <string-name><given-names>R.</given-names><surname>Sufit</surname></string-name>, <string-name><given-names>F. J.</given-names><surname>Nagle</surname></string-name>, and <string-name><given-names>D. P.</given-names><surname>Thomas</surname></string-name>. <year>1992</year><article-title>The effect of pedaling frequency on glycogen depletion rates in type I and type II quadriceps muscle fibers during submaximal cycling exercise</article-title>. <source>Eur. J. Appl. Physiol. Occup. Physiol.</source><volume>65</volume>:<fpage>360</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">1385118</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0002">
                <mixed-citation publication-type="journal" id="phy213575-cit-0002"><string-name><surname>Bailey</surname>, <given-names>S. J.</given-names></string-name>, <string-name><given-names>R. L.</given-names><surname>Varnham</surname></string-name>, <string-name><given-names>F. J.</given-names><surname>DiMenna</surname></string-name>, <string-name><given-names>B. C.</given-names><surname>Breese</surname></string-name>, <string-name><given-names>L. J.</given-names><surname>Wylie</surname></string-name>, and <string-name><given-names>A. M.</given-names><surname>Jones</surname></string-name>. <year>2015</year><article-title>Inorganic nitrate supplementation improves muscle oxygenation, O₂ uptake kinetics, and exercise tolerance at high but not low pedal rates</article-title>. <source>J. Appl. Physiol.</source><volume>118</volume>:<fpage>1396</fpage>–<lpage>1405</lpage>.<pub-id pub-id-type="pmid">25858494</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0004">
                <mixed-citation publication-type="journal" id="phy213575-cit-0004"><string-name><surname>Boorsma</surname>, <given-names>R. K.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Whitfield</surname></string-name>, and <string-name><given-names>L. L.</given-names><surname>Spriet</surname></string-name>. <year>2014</year><article-title>Beetroot juice supplementation does not improve performance of elite 1500‐m runners</article-title>. <source>Med. Sci. Sports Exerc.</source><volume>46</volume>:<fpage>2326</fpage>–<lpage>2334</lpage>.<pub-id pub-id-type="pmid">24781895</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0005">
                <mixed-citation publication-type="journal" id="phy213575-cit-0005"><string-name><surname>Breese</surname>, <given-names>B. C.</given-names></string-name>, <string-name><given-names>M. A.</given-names><surname>McNarry</surname></string-name>, <string-name><given-names>S.</given-names><surname>Marwood</surname></string-name>, <string-name><given-names>J. R.</given-names><surname>Blackwell</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Bailey</surname></string-name>, and <string-name><given-names>A. M.</given-names><surname>Jones</surname></string-name>. <year>2013</year><article-title>Beetroot juice supplementation speeds O<sub>2</sub> uptake kinetics and improves exercise tolerance during severe‐intensity exercise initiated from an elevated metabolic rate</article-title>. <source>Am. J. Physiol.</source><volume>305</volume>:<fpage>R1441</fpage>–<lpage>R1450</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0006">
                <mixed-citation publication-type="journal" id="phy213575-cit-0006"><string-name><surname>Christensen</surname>, <given-names>P. M.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Nyberg</surname></string-name>, and <string-name><given-names>J.</given-names><surname>Bangsbo</surname></string-name>. <year>2013</year><article-title>Influence of nitrate supplementation on VO<sub>2</sub> kinetics and endurance of elite cyclists</article-title>. <source>Scand. J. Med. Sci. Sport</source><volume>23</volume>: <fpage>e21</fpage>–<lpage>e31</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0007">
                <mixed-citation publication-type="journal" id="phy213575-cit-0007"><string-name><surname>Coggan</surname>, <given-names>A. R.</given-names></string-name>, and <string-name><given-names>D. L.</given-names><surname>Costill</surname></string-name>. <year>1984</year><article-title>Biological and technological variability of three anaerobic ergometer tests</article-title>. <source>Int. J. Sports Med.</source><volume>5</volume>:<fpage>142</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">6746177</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0008">
                <mixed-citation publication-type="journal" id="phy213575-cit-0008"><string-name><surname>Coggan</surname>, <given-names>A. R.</given-names></string-name>, <string-name><given-names>J. L.</given-names><surname>Leibowitz</surname></string-name>, <string-name><given-names>C.</given-names><surname>Anderson Spearie</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kadkhodayan</surname></string-name>, <string-name><given-names>DP</given-names><surname>Thomas</surname></string-name>, <string-name><given-names>S</given-names><surname>Ramamurthy</surname></string-name>, et al. <year>2015a</year>
<article-title>Acute dietary nitrate intake improves muscle contractile function in patients with heart failure: a double‐blind, placebo‐controlled, randomized trial</article-title>. <source>Circ. Heart Fail.</source>
<volume>8</volume>:<fpage>914</fpage>–<lpage>920</lpage>.<pub-id pub-id-type="pmid">26179185</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0009">
                <mixed-citation publication-type="journal" id="phy213575-cit-0009"><string-name><surname>Coggan</surname>, <given-names>A. R.</given-names></string-name>, <string-name><given-names>J. L.</given-names><surname>Leibowitz</surname></string-name>, <string-name><given-names>A.</given-names><surname>Kadkhodayan</surname></string-name>, <string-name><given-names>D. T.</given-names><surname>Thomas</surname></string-name>, <string-name><given-names>S.</given-names><surname>Ramamurthy</surname></string-name>, <string-name><given-names>C.</given-names><surname>Anderson Spearie</surname></string-name>, et al. <year>2015b</year>
<article-title>Effect of acute dietary nitrate intake on knee extensor speed and power in healthy men and women</article-title>. <source>Nitric Oxide</source>
<volume>48</volume>:<fpage>16</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">25199856</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0010">
                <mixed-citation publication-type="journal" id="phy213575-cit-0010"><string-name><surname>Coyle</surname>, <given-names>E. F.</given-names></string-name>, <string-name><given-names>D. L.</given-names><surname>Costill</surname></string-name>, and <string-name><given-names>G. R.</given-names><surname>Lesmes</surname></string-name>. <year>1979</year><article-title>Leg extension power and muscle fiber composition</article-title>. <source>Med. Sci. Sports</source><volume>11</volume>:<fpage>12</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">158119</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0011">
                <mixed-citation publication-type="journal" id="phy213575-cit-0011"><string-name><surname>Ferguson</surname>, <given-names>S. K.</given-names></string-name>, <string-name><given-names>C. T.</given-names><surname>Holdsworth</surname></string-name>, <string-name><given-names>J. L.</given-names><surname>Wright</surname></string-name>, <string-name><given-names>A. J.</given-names><surname>Fees</surname></string-name>, <string-name><given-names>J. D.</given-names><surname>Allen</surname></string-name>, <string-name><given-names>A. M.</given-names><surname>Jones</surname></string-name>, et al. <year>2015</year>
<article-title>Microvascular oxygen pressures in muscles composed of different fiber types: impact of dietary nitrate supplementation</article-title>. <source>Nitric Oxide</source>
<volume>38</volume>:<fpage>38</fpage>–<lpage>43</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0012">
                <mixed-citation publication-type="journal" id="phy213575-cit-0012"><string-name><surname>Ghasemi</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>S.</given-names><surname>Zahedi AsI</surname></string-name>, <string-name><given-names>Y.</given-names><surname>Mehrabi</surname></string-name>, <string-name><given-names>N.</given-names><surname>Saadat</surname></string-name>, and <string-name><given-names>F.</given-names><surname>Azizi</surname></string-name>. <year>2008</year><article-title>Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age</article-title>. <source>Life Sci.</source><volume>83</volume>:<fpage>326</fpage>–<lpage>331</lpage>.<pub-id pub-id-type="pmid">18662705</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0013">
                <mixed-citation publication-type="journal" id="phy213575-cit-0013"><string-name><surname>Govoni</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>E. A.</given-names><surname>Jansson</surname></string-name>, <string-name><given-names>E.</given-names><surname>Weitzberg</surname></string-name>, and <string-name><given-names>J. O.</given-names><surname>Lundberg</surname></string-name>. <year>2008</year><article-title>The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash</article-title>. <source>Nitric Oxide</source><volume>19</volume>:<fpage>333</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">18793740</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0014">
                <mixed-citation publication-type="journal" id="phy213575-cit-0014"><string-name><surname>Grasemann</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Storm Van's Gravesande</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Buscher</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Drazen</surname>, <given-names>JM</given-names></string-name>, <string-name><surname>Ratjen</surname>, <given-names>F</given-names></string-name>. <year>2003</year><article-title>Effects of sex and of gene variants in constitutive nitric oxide synthases on exhaled nitric oxide</article-title>. <source>Am. J. Respir. Crit. Care Med.</source><volume>167</volume>:<fpage>1113</fpage>–<lpage>1116</lpage>.<pub-id pub-id-type="pmid">12531780</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0015">
                <mixed-citation publication-type="journal" id="phy213575-cit-0015"><string-name><surname>Guralnik</surname>, <given-names>J. M.</given-names></string-name>, <string-name><given-names>E. M.</given-names><surname>Simonsick</surname></string-name>, <string-name><given-names>L.</given-names><surname>Ferrucci</surname></string-name>, <string-name><given-names>R. J.</given-names><surname>Glynn</surname></string-name>, <string-name><given-names>L. F.</given-names><surname>Berkman</surname></string-name>, <string-name><given-names>D. G.</given-names><surname>Blazer</surname></string-name>, et al. <year>1994</year>
<article-title>A short physical performance battery assessing lower extremity function: association with self‐reported disability and prediction of mortality and nursing home admission</article-title>. <source>J Gerontol</source>
<volume>49</volume>:<fpage>M85</fpage>–<lpage>M94</lpage>.<pub-id pub-id-type="pmid">8126356</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0016">
                <mixed-citation publication-type="journal" id="phy213575-cit-0016"><string-name><surname>Haider</surname>, <given-names>G.</given-names></string-name>, and <string-name><given-names>J. P.</given-names><surname>Folland</surname></string-name>. <year>2014</year><article-title>Nitrate supplementation enhances the contractile properties of human skeletal muscle</article-title>. <source>Med. Sci. Sports Exerc.</source><volume>46</volume>:<fpage>2234</fpage>–<lpage>2243</lpage>.<pub-id pub-id-type="pmid">24681572</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0017">
                <mixed-citation publication-type="journal" id="phy213575-cit-0017"><string-name><surname>Hoon</surname>, <given-names>M. W.</given-names></string-name>, <string-name><given-names>A. M.</given-names><surname>Jones</surname></string-name>, <string-name><given-names>N. A.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>J. R.</given-names><surname>Blackwell</surname></string-name>, <string-name><given-names>E. M.</given-names><surname>Broad</surname></string-name>, <string-name><given-names>B.</given-names><surname>Lundy</surname></string-name>, et al. <year>2014</year>
<article-title>The effect of variable doses of inorganic nitrate‐rich beetroot juice on simulated 2000‐m rowing performance in trained athletes</article-title>. <source>Int. J. Sports Physiol. Perform.</source>
<volume>9</volume>:<fpage>615</fpage>–<lpage>620</lpage>.<pub-id pub-id-type="pmid">24085341</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0018">
                <mixed-citation publication-type="journal" id="phy213575-cit-0018"><string-name><surname>Hoon</surname>, <given-names>M. W.</given-names></string-name>, <string-name><given-names>C.</given-names><surname>Fornuseck</surname></string-name>, <string-name><given-names>P. G.</given-names><surname>Chapman</surname></string-name>, and <string-name><given-names>N. A.</given-names><surname>Johnson</surname></string-name>. <year>2015</year><article-title>The effect of nitrate supplementation on muscle contraction in healthy adults</article-title>. <source>Eur. J. Sport. Sci.</source><volume>15</volume>:<fpage>712</fpage>–<lpage>719</lpage>.<pub-id pub-id-type="pmid">26681629</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0019">
                <mixed-citation publication-type="journal" id="phy213575-cit-0019"><string-name><surname>Hülsmann</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>M.</given-names><surname>Quittan</surname></string-name>, <string-name><given-names>R.</given-names><surname>Berger</surname></string-name>, <string-name><given-names>R.</given-names><surname>Crevenna</surname></string-name>, <string-name><given-names>C.</given-names><surname>Springer</surname></string-name>, <string-name><given-names>M.</given-names><surname>Nuhr</surname></string-name>, et al. <year>2004</year>
<article-title>Muscle strength as a predictor of long‐term survival in severe congestive heart failure</article-title>. <source>Eur. J. Heart Fail.</source>
<volume>6</volume>:<fpage>101</fpage>–<lpage>107</lpage>.<pub-id pub-id-type="pmid">15012925</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0020">
                <mixed-citation publication-type="journal" id="phy213575-cit-0020"><string-name><surname>Ivy</surname>, <given-names>J. L.</given-names></string-name>, <string-name><given-names>R. T.</given-names><surname>Withers</surname></string-name>, <string-name><given-names>G.</given-names><surname>Brose</surname></string-name>, <string-name><given-names>B. D.</given-names><surname>Maxwell</surname></string-name>, and <string-name><given-names>D. L.</given-names><surname>Costill</surname></string-name>. <year>1981</year><article-title>Isokinetic contractile properties of the quadriceps with relation to fiber type</article-title>. <source>Eur. J. Appl. Physiol. Occup. Physiol.</source><volume>47</volume>:<fpage>247</fpage>–<lpage>255</lpage>.<pub-id pub-id-type="pmid">7198035</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0021">
                <mixed-citation publication-type="journal" id="phy213575-cit-0021"><string-name><surname>Jilma</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>J.</given-names><surname>Kastner</surname></string-name>, <string-name><given-names>C.</given-names><surname>Mensik</surname></string-name>, <string-name><given-names>B.</given-names><surname>Vondrovec</surname></string-name>, <string-name><given-names>J.</given-names><surname>Hildebrandt</surname></string-name>, <string-name><given-names>K.</given-names><surname>Krejcy</surname></string-name>, et al. <year>1996</year>
<article-title>Sex differences in concentrations of exhaled nitric oxide and plasma nitrate</article-title>. <source>Life Sci.</source>
<volume>58</volume>:<fpage>469</fpage>–<lpage>476</lpage>.<pub-id pub-id-type="pmid">8569419</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0022">
                <mixed-citation publication-type="journal" id="phy213575-cit-0022"><string-name><surname>Jones</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>B.</given-names><surname>Grassi</surname></string-name>, <string-name><given-names>P. M.</given-names><surname>Christensen</surname></string-name>, <string-name><given-names>P.</given-names><surname>Krustrup</surname></string-name>, <string-name><given-names>J.</given-names><surname>Bangsbo</surname></string-name>, and <string-name><given-names>D. C.</given-names><surname>Poole</surname></string-name>. <year>2011</year><article-title>Slow component of VO<sub>2</sub> kinetics: mechanistic bases and practical applications</article-title>. <source>Med. Sci. Sports Exerc.</source><volume>43</volume>:<fpage>2046</fpage>–<lpage>2062</lpage>.<pub-id pub-id-type="pmid">21552162</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0023">
                <mixed-citation publication-type="journal" id="phy213575-cit-0023"><string-name><surname>Jones</surname>, <given-names>A. M.</given-names></string-name>, <string-name><given-names>S. K.</given-names><surname>Ferguson</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Bailey</surname></string-name>, <string-name><given-names>A.</given-names><surname>Vanhatalo</surname></string-name>, and <string-name><given-names>D. C.</given-names><surname>Poole</surname></string-name>. <year>2016</year><article-title>Fiber‐type specific effects of dietary nitrate</article-title>. <source>Exerc. Sci. Sports Rev.</source><volume>44</volume>:<fpage>53</fpage>–<lpage>60</lpage>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0024">
                <mixed-citation publication-type="journal" id="phy213575-cit-0024"><string-name><surname>Justice</surname>, <given-names>J. N.</given-names></string-name>, <string-name><given-names>L. C.</given-names><surname>Johnson</surname></string-name>, <string-name><given-names>A. E.</given-names><surname>deVan</surname></string-name>, <string-name><given-names>C.</given-names><surname>Cruickshank‐Quinn</surname></string-name>, <string-name><given-names>N.</given-names><surname>Reisdorph</surname></string-name>, <string-name><given-names>C. J.</given-names><surname>Bassett</surname></string-name>, et al. <year>2015</year>
<article-title>Improved motor and cognitive performance with sodium nitrite is related to small muscle metabolite signatures: a pilot trial in middle‐aged and older adults</article-title>. <source>Aging (Albany NY)</source>
<volume>7</volume>:<fpage>1004</fpage>–<lpage>1021</lpage>.<pub-id pub-id-type="pmid">26626856</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0025">
                <mixed-citation publication-type="journal" id="phy213575-cit-0025"><string-name><surname>Kapil</surname>, <given-names>V.</given-names></string-name>, <string-name><given-names>A. B.</given-names><surname>Milsom</surname></string-name>, <string-name><given-names>M.</given-names><surname>Okorie</surname></string-name>, <string-name><given-names>S.</given-names><surname>Maleki‐Toyserkani</surname></string-name>, <string-name><given-names>F.</given-names><surname>Akram</surname></string-name>, <string-name><given-names>F.</given-names><surname>Rehman</surname></string-name>, et al. <year>2010</year>
<article-title>Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite‐derived NO</article-title>. <source>Hypertension</source>
<volume>56</volume>:<fpage>274</fpage>–<lpage>281</lpage>.<pub-id pub-id-type="pmid">20585108</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0026">
                <mixed-citation publication-type="journal" id="phy213575-cit-0026"><string-name><surname>Katz</surname>, <given-names>S. D.</given-names></string-name>, <string-name><given-names>T.</given-names><surname>Khan</surname></string-name>, <string-name><given-names>G. A.</given-names><surname>Zeballos</surname></string-name>, <string-name><given-names>L.</given-names><surname>Mathew</surname></string-name>, <string-name><given-names>P.</given-names><surname>Potharlanka</surname></string-name>, <string-name><given-names>M.</given-names><surname>Knecht</surname></string-name>, et al. <year>1999</year>
<article-title>Decreased activity of the L arginine‐nitric oxide metabolic pathway in patients with congestive heart failure</article-title>. <source>Circulation</source>
<volume>99</volume>:<fpage>2113</fpage>–<lpage>2117</lpage>.<pub-id pub-id-type="pmid">10217650</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0027">
                <mixed-citation publication-type="journal" id="phy213575-cit-0027"><string-name><surname>Lundberg</surname>, <given-names>J. O.</given-names></string-name>, and <string-name><given-names>E.</given-names><surname>Weitzberg</surname></string-name>. <year>2009</year><article-title>NO generation from inorganic nitrate and nitrite: role in physiology, nutrition, and therapeutics</article-title>. <source>Arch. Pharm. Res.</source><volume>32</volume>:<fpage>1119</fpage>–<lpage>1126</lpage>.<pub-id pub-id-type="pmid">19727604</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0028">
                <mixed-citation publication-type="journal" id="phy213575-cit-0028"><string-name><surname>Lundberg</surname>, <given-names>J. O.</given-names></string-name>, <string-name><given-names>E.</given-names><surname>Weitzberg</surname></string-name>, <string-name><given-names>J. M.</given-names><surname>Lundberg</surname></string-name>, and <string-name><given-names>K.</given-names><surname>Alving</surname></string-name>. <year>1994</year><article-title>Intragastic nitric oxide production in humans: measurements in expelled air</article-title>. <source>Gut</source><volume>35</volume>:<fpage>1543</fpage>–<lpage>1546</lpage>.<pub-id pub-id-type="pmid">7828969</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0030">
                <mixed-citation publication-type="journal" id="phy213575-cit-0030"><string-name><surname>Maréchal</surname>, <given-names>G.</given-names></string-name>, and <string-name><given-names>P.</given-names><surname>Gaily</surname></string-name>. <year>1999</year><article-title>Effects of nitric oxide on the contraction of skeletal muscle</article-title>. <source>Cell. Mol. Life Sci.</source><volume>55</volume>:<fpage>1088</fpage>–<lpage>1102</lpage>.<pub-id pub-id-type="pmid">10442090</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0031">
                <mixed-citation publication-type="journal" id="phy213575-cit-0031"><string-name><surname>McCartney</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>G. J.</given-names><surname>Heigenhauser</surname></string-name>, and <string-name><given-names>N. L.</given-names><surname>Jones</surname></string-name>. <year>1983</year><article-title>Power output and fatigue of human muscle in maximal cycling exercise</article-title>. <source>J. Appl. Physiol.</source><volume>55</volume>:<fpage>218</fpage>–<lpage>224</lpage>.<pub-id pub-id-type="pmid">6885573</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0032">
                <mixed-citation publication-type="journal" id="phy213575-cit-0032"><string-name><surname>Montesanti</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>M. L.</given-names><surname>Parisella</surname></string-name>, <string-name><given-names>G.</given-names><surname>Garofalo</surname></string-name>, and <string-name><given-names>D.</given-names><surname>Pellegrino</surname></string-name>. <year>2014</year><article-title>Nitrite as direct S‐nitrosylating agent of Kir2.1 channels</article-title>. <source>Int. Sch. Res. Notices</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2014/517126">https://doi.org/10.1155/2014/517126</ext-link>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0033">
                <mixed-citation publication-type="journal" id="phy213575-cit-0033"><string-name><surname>Münzel</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>T.</given-names><surname>Gori</surname></string-name>, <string-name><given-names>J. F.</given-names><suffix>Jr</suffix><surname>Keaney</surname></string-name>, <string-name><given-names>C.</given-names><surname>Maack</surname></string-name>, and <string-name><given-names>A.</given-names><surname>Daiber</surname></string-name>. <year>2015</year><article-title>Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications</article-title>. <source>Eur. Heart J.</source><volume>36</volume>:<fpage>2555</fpage>–<lpage>2564</lpage>.<pub-id pub-id-type="pmid">26142467</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0034">
                <mixed-citation publication-type="journal" id="phy213575-cit-0034"><string-name><surname>Obach</surname>, <given-names>R. S.</given-names></string-name>, <string-name><given-names>P.</given-names><surname>Huynh</surname></string-name>, <string-name><given-names>M. C.</given-names><surname>Allen</surname></string-name>, and <string-name><given-names>C.</given-names><surname>Beedham</surname></string-name>. <year>2004</year><article-title>Human liver aldehyde oxidase: inhibition by 239 drugs</article-title>. <source>J. Clin. Pharmacol.</source><volume>44</volume>:<fpage>7</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">14681337</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0035">
                <mixed-citation publication-type="journal" id="phy213575-cit-0035"><string-name><surname>Olivieri</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>G.</given-names><surname>Talamini</surname></string-name>, <string-name><given-names>M.</given-names><surname>Corradi</surname></string-name>, <string-name><given-names>L.</given-names><surname>Perbellini</surname></string-name>, <string-name><given-names>A.</given-names><surname>Mutti</surname></string-name>, <string-name><given-names>C.</given-names><surname>Tantucci</surname></string-name>, et al. <year>2006</year>
<article-title>Reference values for exhaled nitric oxide (reveno) study</article-title>. <source>Respir. Res.</source>.<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1465-9921-7-94">https://doi.org/10.1186/1465-9921-7-94</ext-link>.</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0036">
                <mixed-citation publication-type="journal" id="phy213575-cit-0036"><string-name><surname>Rimer</surname>, <given-names>E. G.</given-names></string-name>, <string-name><given-names>L. R.</given-names><surname>Peterson</surname></string-name>, <string-name><given-names>A. R.</given-names><surname>Coggan</surname></string-name>, and <string-name><given-names>J. C.</given-names><surname>Martin</surname></string-name>. <year>2016</year><article-title>Acute dietary nitrate supplementation increases maximal cycling power in athletes</article-title>. <source>Int. J. Sports Physiol. Perform.</source><volume>11</volume>:<fpage>715</fpage>–<lpage>720</lpage>.<pub-id pub-id-type="pmid">26641379</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0037">
                <mixed-citation publication-type="journal" id="phy213575-cit-0037"><string-name><surname>Scichilone</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>S.</given-names><surname>Battaglia</surname></string-name>, <string-name><given-names>F.</given-names><surname>Braido</surname></string-name>, <string-name><given-names>A.</given-names><surname>Collura</surname></string-name>, <string-name><given-names>S.</given-names><surname>Menoni</surname></string-name>, <string-name><given-names>R.</given-names><surname>Arrigo</surname></string-name>, et al. <year>2013</year>
<article-title>Exhaled nitric oxide is associated with cyclic changes in sexual hormones</article-title>. <source>Pulm. Pharmacol. Ther.</source>
<volume>26</volume>:<fpage>644</fpage>–<lpage>648</lpage>.<pub-id pub-id-type="pmid">23665049</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0038">
                <mixed-citation publication-type="journal" id="phy213575-cit-0038"><string-name><surname>Webb</surname>, <given-names>D. J.</given-names></string-name>, <string-name><given-names>S.</given-names><surname>Freestone</surname></string-name>, <string-name><given-names>M. J.</given-names><surname>Allen</surname></string-name>, and <string-name><given-names>G. J.</given-names><surname>Muirhead</surname></string-name>. <year>1999</year><article-title>Sildenafil citrate and blood‐pressure‐lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist</article-title>. <source>Am. J. Cardiol.</source><volume>83</volume>:<fpage>21C</fpage>–<lpage>28C</lpage>.<pub-id pub-id-type="pmid">10073779</pub-id></mixed-citation>
              </ref>
              <ref id="phy213575-bib-0039">
                <mixed-citation publication-type="journal" id="phy213575-cit-0039"><string-name><surname>Whitfield</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>D.</given-names><surname>Gamu</surname></string-name>, <string-name><given-names>G. J. F.</given-names><surname>Heigenhauser</surname></string-name>, <string-name><given-names>L. J. C.</given-names><surname>van Loon</surname></string-name>, <string-name><given-names>L. L.</given-names><surname>Spriet</surname></string-name>, <string-name><given-names>A. R.</given-names><surname>Tupling</surname></string-name>, et al. <year>2017</year>
<article-title>Beetroot juice increases human muscle force without changing Ca<sup>2+</sup>‐handling proteins</article-title>. <source>Med. Sci. Sports Exerc.</source>.<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1249/MSS.0000000000001321">https://doi.org/10.1249/MSS.0000000000001321</ext-link>
</mixed-citation>
              </ref>
              <ref id="phy213575-bib-0040">
                <mixed-citation publication-type="journal" id="phy213575-cit-0040"><string-name><surname>Wilkerson</surname>, <given-names>D. P.</given-names></string-name>, <string-name><given-names>G. M.</given-names><surname>Hayward</surname></string-name>, <string-name><given-names>S. J.</given-names><surname>Bailey</surname></string-name>, <string-name><given-names>A.</given-names><surname>Vanhatalo</surname></string-name>, <string-name><given-names>J. R.</given-names><surname>Blackwell</surname></string-name>, and <string-name><given-names>A. M.</given-names><surname>Jones</surname></string-name>. <year>2012</year><article-title>Influence of acute dietary nitrate supplementation on 50 mile time trial performance in well‐trained cyclists</article-title>. <source>Eur. J. Appl. Physiol.</source><volume>112</volume>:<fpage>4127</fpage>.<pub-id pub-id-type="pmid">22526247</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
